These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33435665)

  • 1. Homobivalent Dopamine D
    Ullmann T; Gienger M; Budzinski J; Hellmann J; Hübner H; Gmeiner P; Weikert D
    ACS Chem Biol; 2021 Feb; 16(2):371-379. PubMed ID: 33435665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?
    Carli M; Kolachalam S; Aringhieri S; Rossi M; Giovannini L; Maggio R; Scarselli M
    Curr Neuropharmacol; 2018 Jan; 16(2):222-230. PubMed ID: 28521704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
    Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivalent approaches and beyond: novel tools for the investigation of dopamine D2 receptor pharmacology.
    Kopinathan A; Scammells PJ; Lane JR; Capuano B
    Future Med Chem; 2016 Jul; 8(11):1349-72. PubMed ID: 27357619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor density influences ligand-induced dopamine D
    Ferraiolo M; Atik H; Ponthot R; Belo do Nascimento I; Beckers P; Stove C; Hermans E
    Eur J Pharmacol; 2021 Nov; 911():174557. PubMed ID: 34626593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-guided development of heterodimer-selective GPCR ligands.
    Hübner H; Schellhorn T; Gienger M; Schaab C; Kaindl J; Leeb L; Clark T; Möller D; Gmeiner P
    Nat Commun; 2016 Jul; 7():12298. PubMed ID: 27457610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers.
    Borroto-Escuela DO; Ravani A; Tarakanov AO; Brito I; Narvaez M; Romero-Fernandez W; Corrales F; Agnati LF; Tanganelli S; Ferraro L; Fuxe K
    Biochem Biophys Res Commun; 2013 May; 435(1):140-6. PubMed ID: 23624386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dopamine D2 receptor dimer and its interaction with homobivalent antagonists: homology modeling, docking and molecular dynamics.
    Kaczor AA; Jörg M; Capuano B
    J Mol Model; 2016 Sep; 22(9):203. PubMed ID: 27491852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dopamine D2 receptor can directly recruit and activate GRK2 without G protein activation.
    Pack TF; Orlen MI; Ray C; Peterson SM; Caron MG
    J Biol Chem; 2018 Apr; 293(16):6161-6171. PubMed ID: 29487132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer.
    Ferré S; Bonaventura J; Tomasi D; Navarro G; Moreno E; Cortés A; Lluís C; Casadó V; Volkow ND
    Neuropharmacology; 2016 May; 104():154-60. PubMed ID: 26051403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer.
    Budzinski J; Maschauer S; Kobayashi H; Couvineau P; Vogt H; Gmeiner P; Roggenhofer A; Prante O; Bouvier M; Weikert D
    Commun Biol; 2021 Sep; 4(1):1062. PubMed ID: 34508168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties.
    Urs NM; Gee SM; Pack TF; McCorvy JD; Evron T; Snyder JC; Yang X; Rodriguiz RM; Borrelli E; Wetsel WC; Jin J; Roth BL; O'Donnell P; Caron MG
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8178-E8186. PubMed ID: 27911814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a true bivalent dopamine D
    Qian M; Ricarte A; Wouters E; Dalton JAR; Risseeuw MDP; Giraldo J; Van Calenbergh S
    Eur J Med Chem; 2021 Feb; 212():113151. PubMed ID: 33450620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine A2A receptor-antagonist/dopamine D2 receptor-agonist bivalent ligands as pharmacological tools to detect A2A-D2 receptor heteromers.
    Soriano A; Ventura R; Molero A; Hoen R; Casadó V; Cortés A; Fanelli F; Albericio F; Lluís C; Franco R; Royo M
    J Med Chem; 2009 Sep; 52(18):5590-602. PubMed ID: 19711895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence against dopamine D1/D2 receptor heteromers.
    Frederick AL; Yano H; Trifilieff P; Vishwasrao HD; Biezonski D; Mészáros J; Urizar E; Sibley DR; Kellendonk C; Sonntag KC; Graham DL; Colbran RJ; Stanwood GD; Javitch JA
    Mol Psychiatry; 2015 Nov; 20(11):1373-85. PubMed ID: 25560761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the Effects of Sodium Ions on the Binding of Antagonists to Dopamine D2 and D3 Receptors.
    Newton CL; Wood MD; Strange PG
    PLoS One; 2016; 11(7):e0158808. PubMed ID: 27379794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RalA employs GRK2 and β-arrestins for the filamin A-mediated regulation of trafficking and signaling of dopamine D2 and D3 receptor.
    Zheng M; Zhang X; Sun N; Min C; Zhang X; Kim KM
    Biochim Biophys Acta; 2016 Aug; 1863(8):2072-83. PubMed ID: 27188791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential allosteric modulation within dopamine D
    Plach M; Schäfer T; Borroto-Escuela DO; Weikert D; Gmeiner P; Fuxe K; Friedland K
    Sci Rep; 2019 Nov; 9(1):16312. PubMed ID: 31704949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bivalent dopamine D2 receptor ligands: synthesis and binding properties.
    Kühhorn J; Hübner H; Gmeiner P
    J Med Chem; 2011 Jul; 54(13):4896-903. PubMed ID: 21599022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis toward Bivalent Ligands for the Dopamine D
    Qian M; Wouters E; Dalton JAR; Risseeuw MDP; Crans RAJ; Stove C; Giraldo J; Van Craenenbroeck K; Van Calenbergh S
    J Med Chem; 2018 Sep; 61(18):8212-8225. PubMed ID: 30180563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.